New ulceration, new major amputation, and survival rates in diabetic subjects hospitalized for foot ulceration from 1990 to 1993: a 6.5-year follow-up
- PMID: 11194246
- DOI: 10.2337/diacare.24.1.78
New ulceration, new major amputation, and survival rates in diabetic subjects hospitalized for foot ulceration from 1990 to 1993: a 6.5-year follow-up
Abstract
Objective: To evaluate 1) the new ulceration, the new major amputation, and the survival rates of 115 diabetic subjects hospitalized for foot ulceration from 1990 to 1993, with an average follow-up of 6.5 years, and 2) the demographic and clinical characteristics associated with these events.
Research design and methods: A total of 115 subjects, 31 women and 84 men, were monitored until 31 December 1998. All subjects were provided with therapeutic shoes and received intense education. Data concerning new ulceration, new major amputation, and reamputation events and the date and cause of death were recorded for each patient. The prognostic factors for these events were then evaluated.
Results: The average follow-up was 78.3 +/- 15.3 months (range 60-106). During this time, 13 homolateral and 12 contralateral episodes of new ulceration occurred. At univariate analysis, none of the variables considered were significantly associated with the new ulceration. There were three major amputations: two of the limb previously healed and one of the contralateral limb. Of the 115 subjects, 51 (44.3%) died: 24 of the 31 women (77.4%) and 27 of the 84 men (32.1%). Ischemic cardiopathy was the most frequent cause of death (60.8%). Mortality concerned 20 of the 27 subjects (74.1%) undergoing major amputation from 1990 to 1993 and 31 of the 88 healed subjects (35.2%), with a significant difference (P < 0.0001). Multivariate analysis showed the independent role of the ankle-brachial index < or =0.5 (P = 0.005), age (P = 0.003), and female sex (P = 0.027).
Conclusions: We believe that the use of therapeutic shoes and intense educational training, including the education of the family, have contributed to the low incidence of new ulceration and major amputation in our study population. The high frequency of ischemic cardiopathy as a cause of death should, perhaps, lead to a more aggressive diagnostic and therapeutic attitude toward this pathology in diabetic subjects admitted to hospitals for foot ulceration.
Similar articles
-
Long-term outcome and disability of diabetic patients hospitalized for diabetic foot ulcers: a 6.5-year follow-up study.Diabetes Care. 2008 Jul;31(7):1288-92. doi: 10.2337/dc07-2145. Epub 2008 Apr 4. Diabetes Care. 2008. PMID: 18390801 Free PMC article.
-
Amputation-free survival in 17,353 people at high risk for foot ulceration in diabetes: a national observational study.Diabetologia. 2018 Dec;61(12):2590-2597. doi: 10.1007/s00125-018-4723-y. Epub 2018 Aug 31. Diabetologia. 2018. PMID: 30171278 Free PMC article.
-
Foot ulceration and lower limb amputation in type 2 diabetic patients in dutch primary health care.Diabetes Care. 2002 Mar;25(3):570-4. doi: 10.2337/diacare.25.3.570. Diabetes Care. 2002. PMID: 11874949
-
Lower Extremity Amputation and Mortality Rates in the Reconstructed Diabetic Charcot Foot and Ankle With External Fixation: Data Analysis of 116 Patients.Foot Ankle Spec. 2016 Apr;9(2):113-26. doi: 10.1177/1938640015599036. Epub 2015 Aug 14. Foot Ankle Spec. 2016. PMID: 26276212
-
A meta-analysis of mortality after minor amputation among patients with diabetes and/or peripheral vascular disease.J Vasc Surg. 2020 Dec;72(6):2197-2207. doi: 10.1016/j.jvs.2020.07.086. Epub 2020 Aug 21. J Vasc Surg. 2020. PMID: 32835790
Cited by
-
Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a decade.Diabetes Care. 2012 Oct;35(10):2021-7. doi: 10.2337/dc12-0200. Epub 2012 Jul 18. Diabetes Care. 2012. PMID: 22815299 Free PMC article.
-
[Orthopedic made-to-measure shoes for diabetics. Long-term 5-year outcome].Orthopade. 2009 Dec;38(12):1209-14. doi: 10.1007/s00132-009-1507-6. Orthopade. 2009. PMID: 19924391 Clinical Trial. German.
-
Resveratrol promotes foot ulcer size reduction in type 2 diabetes patients.ISRN Endocrinol. 2014 Feb 20;2014:816307. doi: 10.1155/2014/816307. eCollection 2014. ISRN Endocrinol. 2014. PMID: 24701359 Free PMC article.
-
Inverse Relationship Between Serum Bilirubin Levels and Diabetic Foot in Chinese Patients with Type 2 Diabetes Mellitus.Med Sci Monit. 2017 Dec 14;23:5916-5923. doi: 10.12659/msm.907248. Med Sci Monit. 2017. PMID: 29238034 Free PMC article.
-
The impact of foot ulceration and amputation on mortality in diabetic patients. I: From ulceration to death, a systematic review.Int Wound J. 2016 Oct;13(5):892-903. doi: 10.1111/iwj.12404. Epub 2015 Jan 20. Int Wound J. 2016. PMID: 25601358 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical